Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

221
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
221
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

177
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
177
Randomized Experiments01:13

Randomized Experiments

8.8K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
8.8K
Group Design02:01

Group Design

10.1K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
10.1K
Crossover Experiments01:16

Crossover Experiments

4.5K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
4.5K
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

258
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
258

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Unified Approach to Covariate Adjustment for Survival Endpoints in Randomized Clinical Trials.

Pharmaceutical statistics·2025
Same author

Addressing Non-Exchangeability in Hybrid Control Studies: A Variable Selection Approach.

Pharmaceutical statistics·2025
Same author

Sample Size for Enriched Biomarker Designs With Measurement Error for Time-to-Event Outcomes.

Pharmaceutical statistics·2025
Same author

Estimation of receiver operating characteristic curve when case and control require different transformations for normality.

Statistical methods in medical research·2025
Same author

A connection between covariate adjustment and stratified randomization in randomized clinical trials.

Statistical methods in medical research·2025
Same author

A Likelihood Perspective on Dose-Finding Study Designs in Oncology.

Pharmaceutical statistics·2024

Related Experiment Video

Updated: Jan 13, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K

An adaptive design for optimizing treatment assignment in randomized clinical trials.

Wei Zhang1, Zhiwei Zhang2, Aiyi Liu3

  • 1State Key Laboratory of Mathematical Sciences, Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing 100190, China.

Biometrics
|January 8, 2026
PubMed
Summary

This study introduces a novel multi-stage adaptive design for randomized clinical trials, optimizing treatment assignment for statistical efficiency. This adaptive approach improves treatment effect estimation, especially with limited prior information, offering significant efficiency gains over traditional designs.

Keywords:
augmentationcovariate adjustmentinterim analysisoptimal designpropensity scoretreatment allocation

More Related Videos

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

587
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.1K

Related Experiment Videos

Last Updated: Jan 13, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K
Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

587
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.1K

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Experimental Design

Background:

  • Optimizing treatment assignment in randomized clinical trials (RCTs) enhances statistical efficiency.
  • Optimal designs depend on conditional variances of potential outcomes, often unknown at the design stage.
  • Existing methods struggle with unreliable or unavailable variance information during trial planning.

Purpose of the Study:

  • To propose a practical, multi-stage adaptive design for RCTs.
  • To allow modification of treatment assignment based on interim data regarding conditional variance functions.
  • To develop and evaluate efficient treatment effect estimators for adaptive designs.

Main Methods:

  • A multi-stage adaptive design allowing interim modifications to the treatment assignment mechanism.
  • Development of consistent and asymptotically normal treatment effect estimators.
  • Approximation of the most efficient estimator by substituting estimated unknown quantities.
  • Simulation studies to compare the proposed design with conventional one-stage designs.

Main Results:

  • The proposed multi-stage adaptive design demonstrated substantial efficiency gains compared to one-stage designs when prior information was limited.
  • The adaptation of the treatment assignment mechanism requires careful consideration for accurate treatment effect estimation.
  • Simulation results support the practical utility and efficiency of the adaptive approach.

Conclusions:

  • The proposed multi-stage adaptive design offers a practical solution for optimizing RCT efficiency when variance information is uncertain.
  • This methodology provides significant efficiency improvements, particularly in early-phase or data-scarce trial settings.
  • The approach was successfully illustrated using real-world data from a stroke clinical trial.